In vitro toxicity of mercury, cadmium, and arsenic to platelet aggregation: Influence of adenylate cyclase and phosphodiesterase activity

In Vitro and Molecular Toxicology: Journal of Basic and Applied Research

Volumn 13, Issue 2, 2000, Pages 137-144

  Vinaya Kumar, S ^a   Bhattacharya, S ^a  

^a VISVA BHARATI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ARSENIC; CADMIUM; CYCLIC AMP; HEAVY METAL; MERCURY; PHOSPHODIESTERASE; XENOBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DOSE RESPONSE; ENZYME ACTIVITY; HOMEOSTASIS; IN VITRO STUDY; MALE; NONHUMAN; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0034426349     PISSN: 10979336     EISSN: None     Source Type: Journal    
DOI: 10.1089/109793300440721     Document Type: Article

References (50)

1. Effects of endogenous and exogenous thiols on the distribution of mercurial compounds in mouse tissues
2. Regulation of cyclic AMP metabolism in human platelets
3. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat
4. Platelet membrane fluidity and aggregation of rabbit platelets
5. Adenylate cyclase in fat cells. 1. Properties and the effects of adrenocorticotropin and fluoride
6. Effects of inorganic ions and of plasma proteins on the aggregation of blood platelets by adenosine diphosphate
7. Mercury binding to the plasma membrane in the rat erythrocytes
8. 203 Hg] mercuric nitrate in the subcellular fractions of rat and fish liver
9. Hormone sensitive adenyl cyclase systems: Properties and function
10. Involvement of mercury in platelet aggregation-Probable mechanism of action
11. Studies on the role of cyclic AMP in platelet function
12. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets
13. 2 receptor number and affinity in human platelet membranes
14. A review of the arsenical cycle in natural waters
15. Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death
16. A protein binding assay for adenosine 3′,5′ monophosphate
17. Thrombosis in human blood coagulation
18. Magnesium modifies the responses of platelets to inhibitory agents which act via cAMP
19. Heavy metals
20. Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine
21. The effects of calcium and magnesium on rabbit blood platelet aggregation in vitro
22. Animal health and hygiene
23. A spectrophotometric method for following initial rate kinetics of blood platelet aggregation
24. A rate equation for blood platelet aggregation
25. Ajonene inhibition of platelet aggregation: Possible mediation by a haemoprotein
26. 2 receptor ligands
27. Molecular basis for ADP-induced platelet activation II. The P2YI receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets
28. The influence of dietary copper on dense granule secretion and cytoskeletal remodelling in thrombin-stimulated rat platelets
29. Altered cytoskeletal organization and secretory response of thrombin activated platelets from copper-deficient rats
30. Intracellular calcium mobilization in rat platelets is adversely affected by copper deficiency
31. Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3′,5′-cyclic monophosphate and protein kinase
32. A simple senstive method for the assay of adenyl cyclase
33. Cyclic adenosine 3′,5′-monophosphate and prostaglandin inhibit membrane phospholipase activity in platelets
34. Relationship of cyclic nucleotides and calcium in platelet function
35. Effect of lead and cadmium on human and rat platelet aggregation
36. Protein measurement with the Folin phenol reagent
37. 2) in human platelets
38. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′,5′-cyclic monophosphate in platelets
39. Induction of metallothionein in rat liver by cadmium chloride: Probable mechanism of action
40. Factors influencing platelet function: Adhesion, release and aggregation
41. Response of platelets to tissue injury
42. Cyclic 3′,5′-adenosine monophosphate in human blood platelets. IV. Regulatory role of the cyclic AMP in platelet function
43. Microvascular responses in copper-deficient rats
44. Hemostatic mechanisms in marginally copper-deficient rats
45. Platelet thrombosis formation and hemostasis in the copper-deficient rat microcirculation
46. Kinetic studies of platelet aggregation induced by adenosine diphosphate and its inhibition by chelating agents, guanidino compounds and adenosine
47. 2 inhibits the aggregation of human platelets
48. Student's t-distribution
49. Low doses of heavy metals disrupt normal structure and function of rat platelets